Global Female Urinary Incontinence Treatment Device Market Growth 2025-2031

The global Female Urinary Incontinence Treatment Device market size is predicted to grow from US$ 1105 million in 2025 to US$ 1683 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.

Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the “Female Urinary Incontinence Treatment Device Industry Forecast” looks at past sales and reviews total world Female Urinary Incontinence Treatment Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Female Urinary Incontinence Treatment Device sales for 2025 through 2031. With Female Urinary Incontinence Treatment Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Female Urinary Incontinence Treatment Device industry.

This Insight Report provides a comprehensive analysis of the global Female Urinary Incontinence Treatment Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Female Urinary Incontinence Treatment Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Female Urinary Incontinence Treatment Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Female Urinary Incontinence Treatment Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Female Urinary Incontinence Treatment Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Female Urinary Incontinence Treatment Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Urethral Devices
Internal Vaginal Devices

Segmentation by Application:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BD
Karl Storz
Johnson and Johnson
Coloplast
Boston Scientific
Teleflex
Medtronic
InControl Medical
Atlantic Therapeutics Group
Axonics Modulation Technologies
Laborie
Micron Medical
American Medical Solutions

Key Questions Addressed in this Report

What is the 10-year outlook for the global Female Urinary Incontinence Treatment Device market?

What factors are driving Female Urinary Incontinence Treatment Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Female Urinary Incontinence Treatment Device market opportunities vary by end market size?

How does Female Urinary Incontinence Treatment Device break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.